[1] Vainionpää R, Hyypiä T. Biology of parainfluenza viruses [J]. Clin. Microbiol. Rev. 1994, 7 (2): 265–75.
[2] Hause BM, Collin EA, et al. Characterization of a novel influenza virus in cattle and swine: proposal for a new genus in the Orthomyxoviridae family [J]. MBio. 2014, 5 (2): e00031–14.
[3] Song H, Qi J, et al. An open receptor-binding cavity of hemagglutinin-esterase-fusion glycoprotein from newly-identified Influenza D Virus: Basis for its broad cell tropism [J]. PLoS Pathog. 2016, 12 (1): e1005411.
[4] Smith DB, Gaunt ER, et al. Detection of influenza C virus but not influenza D virus in Scottish respiratory samples [J]. J Clin Virol. 2016, 74: 50–53.
[5] Stanaway, Jeffrey D; Flaxman, Abraham D, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 [J]. The Lancet. 2016, 388 (10049): 1081–8.
[6] Su-Hyung Park1 and Barbara Rehermann. Immune Responses to HCV and Other Hepatitis Viruses [J]. Immunity.2014, 40(1):13-24.
[7] ouek DC, Roederer M, et al. Emerging Concepts in the Immunopathogenesis of AIDS [J]. Annual Review of Medicine. 2009, 60: 471–84.
[8] Hariri S,McKenna MT. Epidemiology of human immunodeficiency virus in the United States [J]. Clin Microbiol Rev. 2007, 20(3): 478-88.
[9] Gilbert PB, McKeague IW, E; et al. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal [J]. Statistics in Medicine. 2003, 22 (4): 573–593.
[10] Reeves JD, Doms RW. Human Immunodeficiency Virus Type 2 [J]. Journal of General Virology. 2002, 83 (Pt 6): 1253–65.
[11] inke S, Conzelmann KK. Replication strategies of rabies virus [J]. Virus Res. 2005, 111 (2): 120–131.
[12] Maeda E, Akahane M, et al. Spectrum of Epstein–Barr virus-related diseases: a pictorial review [J]. Jpn J Radiol. 2009, 27 (1): 4–19.
[13] Odumade, O. A.; Hogquist, Balfour. Progress and Problems in Understanding and Managing Primary Epstein–Barr Virus Infections [J]. American Society for Microbiology. 2011, 24 (1): 193–209.
[14] Weiss, LM; O'Malley, D. Benign lymphadenopathies [J]. Modern Pathology. 2013, 26 (Supplement 1): S88–S96.
[15] Dogan, S; Hedberg, ML; et al. Human papillomavirus and Epstein–Barr virus in nasopharyngeal carcinoma in a low-incidence population [J]. Head & neck. 2014, 36 (4): 511–6.
[16] Mechelli R, Manzari C, et al. Epstein–Barr virus genetic variants are associated with multiple sclerosis [J]. Neurology. 2015, 84 (13): 1362–8.